FLT3 and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast, AML cells that express endogenous FLT3, however, hardly showed TAZ induction even upon imatinib treatment, which suggests FLT3-TAZ signaling may be a unique mechanism of CML (Fig. S3B).